EC grants marketing authorisation for IntraBio’s Aqneursa

Monday, June 8, 2026Salong DebbarmaView original

The European Commission (EC) has granted marketing authorisation for IntraBio’s Aqneursa to treat neurological symptoms of NPC.

Read the full article on the original site.